Eve Investments logo

EVE - Eve Investments Share Price

A$0.005 0.0  12.5%

Last Trade - 07/04/20

Sector
Financials
Size
Micro Cap
Market Cap £6.80m
Enterprise Value £6.54m
Revenue £645k
Position in Universe 1228th / 1833
Bullish
Bearish
Unlock EVE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

EVE Revenue Unlock EVE Revenue

Net Income

EVE Net Income Unlock EVE Revenue

Normalised EPS

EVE Normalised EPS Unlock EVE Revenue

PE Ratio Range

EVE PE Ratio Range Unlock EVE Revenue

Dividend Yield Range

EVE Dividend Yield Range Unlock EVE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EVE EPS Forecasts Unlock EVE Revenue
Profile Summary

EVE Investments Limited, formerly Energy Ventures Limited, is an Australia-based investment company that invests in technology companies. The Company has an interest in Wayland Copper, which holds the Ballek copper-gold in Northern Sweden. It also holds an interest in Agricola Resources Plc, which is focusing on undergoing a corporate restructure and is seeking a new project. The Company owns an interest in Omni Innovation, a medical nutrition company focused on creating products, tools and technologies for foods for special medical purposes. Omni Innovation is developing dietary interventions for common chronic diseases, such type II diabetes and low blood pressure (hypotension). Omni Innovation's product, GlucoControl, is a pre-meal drink for people with pre-diabetes or type II diabetes.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated October 1, 2003
Public Since June 12, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Financials
Industry Investment Banking & Investment Services
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 3,034,826,653
Free Float (0.0%)
Eligible for
ISAs
SIPPs
EVE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for EVE
Upcoming Events for EVE
Similar to EVE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.